The same attention to the control of active infection is needed when treating patients affected also by cardiovascular diseases (CVD): it has been demonstrated how high serum levels of c-reactive protein (CRP) are major predictors for high serum and salivary levels of endothelin 1 (ET-1). The gene discussed is CRP; the disease is infection.